Bayer AG ADR

BAYRY: OTCM (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|.#LOCK|v<LOCK|^RL

Bayer's Near-Term Outlook Dominated by Generic Pressures and Crop Science Uncertainty

Business Strategy and Outlook

We believe Bayer has created a narrow economic moat on the basis of the competitive advantages of the healthcare group. We believe its crop science business holds few synergies with the prescription drug business.

Sponsor Center